Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04187521 · ClinicalTrials.gov registry record · NA
Heterogeneity Informed Nutrition Therapy for Gestational Diabetes Mellitus
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04187521: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04187521 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04187521, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The hypothesis for this study is that women with different physiologic subtypes of gestational diabetes (GDM) (insulin secretion deficit vs. insulin sensitivity deficit) will differ in their glycemic responses to meals with different portions of dietary macronutrients. Investigators will determine GDM subtype based on glucose and insulin levels taken at multiple time points during an oral glucose tolerance test. Participants will consume two meals with different macronutrient content while wearing a continuous glucose monitor which will allow investigators to assess the glycemic response to the meals.
Interventions
- OTHER Meal A
- OTHER Meal B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04187521
The ClinicalTrials.gov registry entry for NCT04187521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Meal A is the first listed.
NCT04187521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04187521 about?
NCT04187521 is a clinical study titled "Heterogeneity Informed Nutrition Therapy for Gestational Diabetes Mellitus". The hypothesis for this study is that women with different physiologic subtypes of gestational diabetes (GDM) (insulin secretion deficit vs. insulin sensitivity deficit) will differ in their glycemic responses to meals with different portions of dietary macronutrients. Investigators will determine G...
What is the current status of trial NCT04187521?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2020-02-10. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04187521?
The interventions under investigation include: Meal A (OTHER), Meal B (OTHER).
Who is sponsoring clinical trial NCT04187521?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.